메뉴 건너뛰기




Volumn 14, Issue 3, 2004, Pages 167-176

Canine parvoviral enteritis: A review of diagnosis, management, and prevention

Author keywords

Immunomodulation; Leukopenia; Parvovirus; SIRS; Vaccination

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BAYTIL; BETA LACTAM ANTIBIOTIC; BISMUTH SALICYLATE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GENTAMICIN; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; ONDANSETRON; OPIATE; POTASSIUM CHLORIDE; RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; RECOMBINANT INTERFERON OMEGA; UNCLASSIFIED DRUG; VIRUS VACCINE;

EID: 13444274355     PISSN: 14793261     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1534-6935.2004.04020.x     Document Type: Review
Times cited : (139)

References (49)
  • 1
    • 13444271030 scopus 로고
    • Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies
    • Kariuki NM, Nyaga PN, Buoro IBJ, et al. Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies. Bull Anim Health Prod Afr 1990; 38:379-389.
    • (1990) Bull Anim Health Prod Afr , vol.38 , pp. 379-389
    • Kariuki, N.M.1    Nyaga, P.N.2    Buoro, I.B.J.3
  • 2
    • 0032068790 scopus 로고    scopus 로고
    • Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis
    • Mann FA, Boon GD, Wagner-Mann CC, et al. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 1998; 212:1398-1401.
    • (1998) J Am Vet Med Assoc , vol.212 , pp. 1398-1401
    • Mann, F.A.1    Boon, G.D.2    Wagner-Mann, C.C.3
  • 3
    • 0022426640 scopus 로고
    • Breed-related risk factors for canine parvovirus enteritis
    • Glickman LT, Domanski LM, Patronek GJ, et al. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 1985; 187:589-584.
    • (1985) J Am Vet Med Assoc , vol.187 , pp. 589-1584
    • Glickman, L.T.1    Domanski, L.M.2    Patronek, G.J.3
  • 4
    • 0031088556 scopus 로고    scopus 로고
    • Endotoxemia and tumor necrosis factor in clinical canine parvoviral eneteritis
    • Otto CM, Drobatz K, Soter C. Endotoxemia and tumor necrosis factor in clinical canine parvoviral eneteritis. J Vet Intern Med 1997; 11:65-70.
    • (1997) J Vet Intern Med , vol.11 , pp. 65-70
    • Otto, C.M.1    Drobatz, K.2    Soter, C.3
  • 5
    • 0035409425 scopus 로고    scopus 로고
    • 21) for treatment of parvovirus enteritis: A randomized, double-blinded, placebo-controlled trial
    • 21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial. J Vet Intern Med 2001; 15:355-360.
    • (2001) J Vet Intern Med , vol.15 , pp. 355-360
    • Otto, C.M.1    Jackson, C.B.2    Rogell, E.J.3
  • 8
    • 0009839849 scopus 로고
    • Clinical, pathological, and epidemiological aspects of canine parvovirus in an unvaccinated beagle colony: 1978-1985
    • Mason MJ, Gillet NA, Muggenburh BA. Clinical, pathological, and epidemiological aspects of canine parvovirus in an unvaccinated beagle colony: 1978-1985. J Amer Anim Hosp Assoc 1987; 23:183.
    • (1987) J Amer Anim Hosp Assoc , vol.23 , pp. 183
    • Mason, M.J.1    Gillet, N.A.2    Muggenburh, B.A.3
  • 9
    • 0028068324 scopus 로고
    • Serologic response of pups to the low-passage modified-live canine parvovirus-2 component in a compound vaccine
    • O'Brien SE. Serologic response of pups to the low-passage modified-live canine parvovirus-2 component in a compound vaccine. J Am Vet Med Assoc 1994; 204:1207-1209.
    • (1994) J Am Vet Med Assoc , vol.204 , pp. 1207-1209
    • O'Brien, S.E.1
  • 10
    • 0030584197 scopus 로고    scopus 로고
    • Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991)
    • Houston DM, Ribble CS, Head LL. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991). J Am Vet Med Assoc 1996; 208:542-546.
    • (1996) J Am Vet Med Assoc , vol.208 , pp. 542-546
    • Houston, D.M.1    Ribble, C.S.2    Head, L.L.3
  • 11
    • 0042995039 scopus 로고
    • Canine parvovirus infection: Effects on the immune system and factors that predispose to severe disease
    • Brunner CJ, Swango LJ. Canine parvovirus infection: effects on the immune system and factors that predispose to severe disease. Comp Cont Ed Pract Vet 1985; 7(12): 979-989.
    • (1985) Comp Cont Ed Pract Vet , vol.7 , Issue.12 , pp. 979-989
    • Brunner, C.J.1    Swango, L.J.2
  • 13
    • 0032607313 scopus 로고    scopus 로고
    • Subscute massive necrotizing myocarditis by canine parvovirus type-2 infection with diffuse leukoencephalomalacia in a puppy
    • Agungpriyono DR, Uchida K, Tabaru H, et al. Subscute massive necrotizing myocarditis by canine parvovirus type-2 infection with diffuse leukoencephalomalacia in a puppy. Vet Path 1999; 36:77-80.
    • (1999) Vet Path , vol.36 , pp. 77-80
    • Agungpriyono, D.R.1    Uchida, K.2    Tabaru, H.3
  • 14
    • 0345869594 scopus 로고    scopus 로고
    • Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment
    • Macintire DK, Smith-Carr S. Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment. Comp Cont Ed Pract Vet 1997; 19(3):291-300.
    • (1997) Comp Cont Ed Pract Vet , vol.19 , Issue.3 , pp. 291-300
    • Macintire, D.K.1    Smith-Carr, S.2
  • 15
    • 0025391502 scopus 로고
    • Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988)
    • Turk J, Miller M, Brown T, et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988). J Am Vet Med Assoc 1990; 200:991-994.
    • (1990) J Am Vet Med Assoc , vol.200 , pp. 991-994
    • Turk, J.1    Miller, M.2    Brown, T.3
  • 16
    • 0026847024 scopus 로고
    • Enteric Clostridium perfringens infection associated with parvoviral enteritis in dogs: 74 cases (1987-1990)
    • Turk J, Fales W, Miller M, et al. Enteric Clostridium perfringens infection associated with parvoviral enteritis in dogs: 74 cases (1987-1990). J Am Vet Med Assoc 1992; 200:991-994.
    • (1992) J Am Vet Med Assoc , vol.200 , pp. 991-994
    • Turk, J.1    Fales, W.2    Miller, M.3
  • 17
    • 0019553765 scopus 로고
    • Concomitant occurrence of Campylobacter and parvoviruses in dogs with gastroenteritis
    • Sandstedt K, Wienup M. Concomitant occurrence of Campylobacter and parvoviruses in dogs with gastroenteritis. Vet Res Comm 1981; 4:271-273.
    • (1981) Vet Res Comm , vol.4 , pp. 271-273
    • Sandstedt, K.1    Wienup, M.2
  • 18
    • 0032159095 scopus 로고    scopus 로고
    • The sepsis-coagulant axis: A review
    • Weiss DJ, Rashid J. The sepsis-coagulant axis: a review. J Vet Intern Med 1998; 12:317-324.
    • (1998) J Vet Intern Med , vol.12 , pp. 317-324
    • Weiss, D.J.1    Rashid, J.2
  • 19
    • 0032446765 scopus 로고    scopus 로고
    • Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock
    • Gando S, Nanzaki S, Sasaki S, et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26:2005-2009.
    • (1998) Crit Care Med , vol.26 , pp. 2005-2009
    • Gando, S.1    Nanzaki, S.2    Sasaki, S.3
  • 20
    • 0034668755 scopus 로고    scopus 로고
    • Evidence of hypercoagulability in dogs with parvoviral enteritis
    • Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217(10):1500-1504.
    • (2000) J Am Vet Med Assoc , vol.217 , Issue.10 , pp. 1500-1504
    • Otto, C.M.1    Rieser, T.M.2    Brooks, M.B.3
  • 22
    • 0027635835 scopus 로고
    • Comparison of polymerase chain reaction with virus isolation and hemoagglutination assays for the detection of canine parvoviruses in faecal specimens
    • Mochizuki M, San Gabriel MC, Nakatani H, et al. Comparison of polymerase chain reaction with virus isolation and hemoagglutination assays for the detection of canine parvoviruses in faecal specimens. Res Vet Sci 1993; 55:60-63.
    • (1993) Res Vet Sci , vol.55 , pp. 60-63
    • Mochizuki, M.1    San Gabriel, M.C.2    Nakatani, H.3
  • 23
    • 0012963836 scopus 로고
    • Serologic studies on the incidence of canine viral enteritis viruses
    • Helfer-Baker C, Evermann JF, McKeirnan AJ, et al. Serologic studies on the incidence of canine viral enteritis viruses. Canine Pract 1980; 7:37.
    • (1980) Canine Pract , vol.7 , pp. 37
    • Helfer-Baker, C.1    Evermann, J.F.2    McKeirnan, A.J.3
  • 24
    • 85047690190 scopus 로고
    • A paradigm for consensus: The university hospital consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions
    • Vermeulen LC, Ratko TA, Erstad BL, et al. A paradigm for consensus: the university hospital consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995; 155:373-379.
    • (1995) Arch Intern Med , vol.155 , pp. 373-379
    • Vermeulen, L.C.1    Ratko, T.A.2    Erstad, B.L.3
  • 25
    • 0032566220 scopus 로고    scopus 로고
    • Human albumin administration in critically ill patients: Systematic review of randomized controlled trial
    • Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trial. Br Med J 1998; 317:235-240.
    • (1998) Br Med J , vol.317 , pp. 235-240
  • 26
    • 0035822614 scopus 로고    scopus 로고
    • Patient survival after human albumin administration: A meta-analysis of randomized, controlled trials
    • Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135:149-164.
    • (2001) Ann Intern Med , vol.135 , pp. 149-164
    • Wilkes, M.M.1    Navickis, R.J.2
  • 27
    • 12744275562 scopus 로고    scopus 로고
    • The role of albumin replacement in the critically ill veterinary patient
    • Mazzaferro EM, Rudloff E, Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emer Crit Care 2002; 12(2):113-124.
    • (2002) J Vet Emer Crit Care , vol.12 , Issue.2 , pp. 113-124
    • Mazzaferro, E.M.1    Rudloff, E.2    Kirby, R.3
  • 28
    • 0028197285 scopus 로고
    • Bactericidal antibiotics increase tumor necrosis factor alpha and cardiac output in rats after cecal ligation and puncture
    • Stockwell JA, Huang YC, Su YF, et al. Bactericidal antibiotics increase tumor necrosis factor alpha and cardiac output in rats after cecal ligation and puncture. Circ Shock 1994; 42:68-75.
    • (1994) Circ Shock , vol.42 , pp. 68-75
    • Stockwell, J.A.1    Huang, Y.C.2    Su, Y.F.3
  • 29
    • 0027251709 scopus 로고
    • Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis
    • Tsukada K, Katoh H, Shiojima M, et al. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis. APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica) 1993; 101:97-100.
    • (1993) APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica) , vol.101 , pp. 97-100
    • Tsukada, K.1    Katoh, H.2    Shiojima, M.3
  • 30
    • 0034870720 scopus 로고    scopus 로고
    • Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis
    • Mischke R, Barth T, Wohlsein P, et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001; 70:221-225.
    • (2001) Res Vet Sci , vol.70 , pp. 221-225
    • Mischke, R.1    Barth, T.2    Wohlsein, P.3
  • 31
    • 0042241734 scopus 로고    scopus 로고
    • Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part 1. Oncology
    • Henry CJ, Buss MS, Lothrop CD. Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part 1. Oncology. Comp Cont Ed Pract Vet 1998; 20(6):728-735.
    • (1998) Comp Cont Ed Pract Vet , vol.20 , Issue.6 , pp. 728-735
    • Henry, C.J.1    Buss, M.S.2    Lothrop, C.D.3
  • 32
    • 0023692094 scopus 로고
    • Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor
    • Lothrop CD, Warren DJ, Souza LM, et al. Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 1988; 72:1324-1328.
    • (1988) Blood , vol.72 , pp. 1324-1328
    • Lothrop, C.D.1    Warren, D.J.2    Souza, L.M.3
  • 33
    • 0042742842 scopus 로고    scopus 로고
    • Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part II. Infectious diseases
    • Rewarts JM, Heny CJ. Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part II. Infectious diseases. Comp Cont Ed Pract Vet 1998; 20(7): 823-829.
    • (1998) Comp Cont Ed Pract Vet , vol.20 , Issue.7 , pp. 823-829
    • Rewarts, J.M.1    Heny, C.J.2
  • 34
    • 0029447816 scopus 로고
    • Treatment of severe neutropenias in the dog and cat with Filgrastim
    • Kraft W, Kuffer M. Treatment of severe neutropenias in the dog and cat with Filgrastim. Tierarztl Prax 1995; 23:609-613.
    • (1995) Tierarztl Prax , vol.23 , pp. 609-613
    • Kraft, W.1    Kuffer, M.2
  • 35
    • 0026093357 scopus 로고
    • Chronic neutropenia: A new canine model induced by human granulocyte colony-stimulating factor
    • Hammond WP, Csiba E, Canin A, et al. Chronic neutropenia: a new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 1991; 87:704-710.
    • (1991) J Clin Invest , vol.87 , pp. 704-710
    • Hammond, W.P.1    Csiba, E.2    Canin, A.3
  • 36
    • 0042995039 scopus 로고
    • Canine parvovirus infection: Effects on the immune system and factors that predispose to severe disease
    • Brunner CJ, Swango LJ. Canine parvovirus infection: effects on the immune system and factors that predispose to severe disease. Comp Cont Ed Pract Vet 1985; 7(12): 979-989.
    • (1985) Comp Cont Ed Pract Vet , vol.7 , Issue.12 , pp. 979-989
    • Brunner, C.J.1    Swango, L.J.2
  • 37
    • 0031785859 scopus 로고    scopus 로고
    • Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection
    • Rewerts JM, McCaw DL, Cohn LA, et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998; 213: 991-992.
    • (1998) J Am Vet Med Assoc , vol.213 , pp. 991-992
    • Rewerts, J.M.1    McCaw, D.L.2    Cohn, L.A.3
  • 38
    • 0008511292 scopus 로고
    • Clinical experience with cross-protective anitendotoxin antiserum in dogs with parvoviral enteritis
    • Dimmit R. Clinical experience with cross-protective anitendotoxin antiserum in dogs with parvoviral enteritis. Canine Pract 1991; 16:23-26.
    • (1991) Canine Pract , vol.16 , pp. 23-26
    • Dimmit, R.1
  • 39
    • 0031776895 scopus 로고    scopus 로고
    • The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense
    • Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64:14-18.
    • (1998) J Leukoc Biol , vol.64 , pp. 14-18
    • Elsbach, P.1
  • 40
    • 0031583752 scopus 로고    scopus 로고
    • Preliminary evaluation of recombinant amino-terminal fragment of bactericidal/permeability increasing protein in children with severe meningococcal sepsis
    • Giroir BP, Quint PA, Baron P, et al. Preliminary evaluation of recombinant amino-terminal fragment of bactericidal/permeability increasing protein in children with severe meningococcal sepsis. Lancet 1997; 350:1439-1443.
    • (1997) Lancet , vol.350 , pp. 1439-1443
    • Giroir, B.P.1    Quint, P.A.2    Baron, P.3
  • 41
    • 0030025638 scopus 로고    scopus 로고
    • Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability increasing protein and cefamandole in treatment of rabbit gram-negative sepsis
    • Lin Y, Leach WJ, Ammons WS. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability increasing protein and cefamandole in treatment of rabbit gram-negative sepsis. Antimicrob Agents Chemother 1996; 40:65-69.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 65-69
    • Lin, Y.1    Leach, W.J.2    Ammons, W.S.3
  • 42
    • 0032133254 scopus 로고    scopus 로고
    • Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in beagle dogs
    • Ishiwata K, Minagawa T, Kajimoto T. Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in beagle dogs. J Vet Med Sci 1998; 60(8):911-917.
    • (1998) J Vet Med Sci , vol.60 , Issue.8 , pp. 911-917
    • Ishiwata, K.1    Minagawa, T.2    Kajimoto, T.3
  • 43
    • 0037159109 scopus 로고    scopus 로고
    • Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial
    • Martin V, Najbar W, Gueguen S, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002; 89:115-127.
    • (2002) Vet Microbiol , vol.89 , pp. 115-127
    • Martin, V.1    Najbar, W.2    Gueguen, S.3
  • 44
    • 0037464635 scopus 로고    scopus 로고
    • Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial
    • de Mari K, Maynard L, Eun HM, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003; 152:105-108.
    • (2003) Vet Rec , vol.152 , pp. 105-108
    • De Mari, K.1    Maynard, L.2    Eun, H.M.3
  • 46
    • 0020039714 scopus 로고
    • Maternally derived immunity to canine parvovirus infection: Transfer, decline, and interference with vaccination
    • Pollock RVH, Carmichael LE. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 1982; 180:37-42.
    • (1982) J Am Vet Med Assoc , vol.180 , pp. 37-42
    • Pollock, R.V.H.1    Carmichael, L.E.2
  • 47
    • 0030256639 scopus 로고    scopus 로고
    • Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay
    • Waner T, Naveh A, Wudovsky I, et al. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. J Vet Diag Invest 1996; 8:427-432.
    • (1996) J Vet Diag Invest , vol.8 , pp. 427-432
    • Waner, T.1    Naveh, A.2    Wudovsky, I.3
  • 48
    • 0026671908 scopus 로고
    • Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine
    • Buonavoglia C, Tollis M, Buonavoglia D, et al. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine. Comp Immunol Microbiol Infect Dis 1992; 15:281-283.
    • (1992) Comp Immunol Microbiol Infect Dis , vol.15 , pp. 281-283
    • Buonavoglia, C.1    Tollis, M.2    Buonavoglia, D.3
  • 49
    • 0034295292 scopus 로고    scopus 로고
    • Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs
    • Twark L, Dodds WJ. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs. J Am Vet Med Assoc 2000; 217(7):1021-1025.
    • (2000) J Am Vet Med Assoc , vol.217 , Issue.7 , pp. 1021-1025
    • Twark, L.1    Dodds, W.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.